Dermatitis Research Review Issue 16
In this issue:
Murine study links maternal stress during pregnancy to paediatric AD
Flares important for assessment of AD severity and disease prognosis
Lebrikizumab efficacious for AD inadequately controlled with cyclosporine
Low risk of adverse events with topical ruxolitinib: should US boxed warning be reconsidered?
Topical ruxolitinib may be as effective as systemic agents for moderate disease
DAMASK fails to demonstrate efficacy for IRAK4 inhibitor zabedosertib
Blood transcriptome signature predicts efficacy of abrocitinib
Is the effectiveness of upadacitinib reduced in patients who failed prior biologic therapy?
Dupilumab associated with weight gain
Clinical course of disease after dupilumab discontinuation
Expert contributor
Associate Professor John Frew
Associate Professor John Frew is a fellow of the Australasian College of Dermatologists and researcher in the field of inflammatory skin diseases with a focus on hidradenitis suppurativa. He holds a staff specialist position at Liverpool Hospital, and is a conjoint lecturer at the University of New South Wales supervising dermatology trainees and postgraduate research […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.